中药饮片产业发展现状及供给侧问题与对策
投稿时间:2022-11-07     点此下载全文
引用本文:郁红礼,李林,金传山,杜伟峰,马恩耀,张伟,季德,张兴德,彭瑞潭,申诺,陆兔林.中药饮片产业发展现状及供给侧问题与对策[J].中国现代中药,2024,26(3):439-446
DOI:10.13313/j.issn.1673-4890.20221107002
摘要点击次数: 107
全文下载次数: 0
                                
作者中文名作者英文名单位中文名单位英文名E-Mail
郁红礼 YU Hong-li 南京中医药大学 药学院,江苏 南京 210023 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China  
李林 LI Lin 南京中医药大学 药学院,江苏 南京 210023 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China  
金传山 JIN Chuan-shan 安徽中医药大学 药学院,安徽 合肥 230012 School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China  
杜伟峰 DU Wei-feng 浙江中医药大学 中药饮片有限公司,浙江 杭州 311401 Zhejiang Chinese Medical University Medical Pieces Co., Ltd., Hangzhou 311401, China  
马恩耀 MA En-yao 广州采芝林药业有限公司,广东 广州 510145 Guangzhou Caizhilin Pharmaceutical Co., Ltd., Guangzhou 510145, China  
张伟 ZHANG We 南京中医药大学 药学院,江苏 南京 210023
安徽中医药大学 药学院,安徽 合肥 230012
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China
School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
 
季德 JI De 南京中医药大学 药学院,江苏 南京 210023 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China  
张兴德 ZHANG Xing-de 南京中医药大学 药学院,江苏 南京 210023 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China  
彭瑞潭 PENG Rui-tan 保和堂(亳州)制药有限公司,安徽 亳州 236800 Baohetang (Bozhou) Pharmaceutical Co., Ltd., Bozhou 236800, China  
申诺* SHEN Nuo 中国中药协会,北京 100061 China Association of Traditional Chinese Medicine, Beijing 100061, China  
陆兔林* LU Tu-lin 南京中医药大学 药学院,江苏 南京 210023 School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210032, China  
基金项目:工业和信息化部“中药产业高质量发展政策研究”课题(2020)
中文摘要:分析了中药饮片产业及市场规模现状,相关法律、法规、政策等,从供给侧剖析产业发展瓶颈,解析中药饮片生产标准化、规模化程度低,技术及产品创新不足,缺少协调供需平衡的宏观统筹问题,提出加强炮制理论基础研究、提高中药饮片生产标准化水平的对策措施,包括提高中药炮制技术的标准化水平、完善质量控制标准、建立等级标准等,倡导提高产业规模化水平、实施大品种战略、鼓励科技创新、组建创新联合体,加快中药饮片数字化、智能化生产管理研发及新产品研发,并从调控供需平衡角度提出了推进中药饮片区域化生产与流通的措施等,以期构建以高品质中药饮片为核心的创新型产业发展格局,探寻振兴中药饮片产业高质量发展之路。
中文关键词:中药饮片产业  发展现状  标准化  规模化  供需平衡  创新生产
 
Development Status, Supply Side Bottleneck Problems and Countermeasures of Chinese Materia Medica Decoction Pieces Industry
Abstract:This paper analyzed the current scale of the Chinese materia medica decoction pieces (CMMDPs) market,the impact of relevant laws, regulations and policy documents and the production status on CMMDPs industry. This paper analyzed the bottlenecks that restrict CMMDPs industry development from the perspective of supply side. This mainly includes standardization of production of decoction pieces, low level of scale, insufficient technological and product innovation, and a lack of macro coordination methods for coordinating the supply and demand balance of decoction pieces. In response to the above issues, countermeasures are proposed to strengthen basic research on processing theory and improve the standardization level of decoction piece production, including improving the standardization level of CMM processing technology, improving the quality standards of CMMDPs, and establishing quality standards for the grade of CMMDPs. It is also proposed to improve the industrial scale level and implement a large-scale variety strategy, encourage technological innovation, form innovation consortia, accelerate the research and development of digital intelligent production management and new product research and development of decoction pieces. And from the perspective of macro regulation of the supply and demand balance of CMMDPs, measures have been proposed to promote the regional production and circulation of decoction pieces, so as to build an innovative industrial development pattern centered on high-quality CMMDPs and explore the path to revitalizing the high-quality development of CMMDPs industry.
keywords:Chinese materia medica decoction pieces industry  development status  standardization  scale up  supply and demand balance  innovative production
查看全文   查看/发表评论  下载PDF阅读器